September 18, 2018
- FDA Education Blueprint for Health Care Providers Involved in the Management or Support of Patients with Pain (PDF - 141 KB )
- FDA Press Release: FDA takes important steps to encourage appropriate and rational prescribing of opioids through final approval of new safety measures governing the use of immediate-release opioid analgesic medications
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drug Trial Snapshot: XERAVA
- Drugs@FDA Data Files (updated)
- Ketoconazole (Nizoral) 2% Shampoo (New - Discontinuation)
- Fluorescein Strips (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Ondansetron Hydrochloride Injection (Updated - Currently in Shortage)
- Rocuronium Bromide Injection (Updated - Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated - Currently in Shortage)
- Sterile Water (Updated - Currently in Shortage)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario